ConductScience.org, home

Paper14734005

Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy.

Pectasides D and 6 others. Eur Urol, 2004. Cited by 25 papers, by iCite.

Cite this record

ConductScience Library. Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy. Papers, record 14734005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14734005

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy.
PubMed
Journal
Eur Urol
PubMed
Year
2004
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
25
iCite
Relative citation ratio, by iCite
0.66
iCite
Revised in PubMed
2019-08-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pectasides DDimitrios
2Pectasides MMelina
3Farmakis DDimitrios
4Nikolaou MMaria
5Koumpou MMaria
6Kostopoulou VVassiliki
7Mylonakis NNikolaos

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
GerminomaMajor topic
Testicular NeoplasmsMajor topic
Adolescent
Adult
Antineoplastic Agents
Bleomycin
Carboplatin
Etoposide
Hormones
Humans
Male
Neoplasm Staging
Sperm Count
Time Factors

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.

PMIDTitleJournalYearIn PapersSource
39189883Oncological treatments have limited effects on the fertility prognosis in testicular cancer: A systematic review and meta-analysis.Andrology2025https://conductscience.org/library/papers/39189883PubMed
35905486Testicular cancer survivorship: Long-term toxicity and management.Can Urol Assoc J2022https://conductscience.org/library/papers/35905486PubMed
33333716Non-Steroidal Anti-Inflammatory Drugs Increase Cisplatin, Paclitaxel, and Doxorubicin Efficacy against Human Cervix Cancer Cells.Pharmaceuticals (Basel)2020https://conductscience.org/library/papers/33333716PubMed
30353257Preservation of fertility of adult male cancer patients treated with chemotherapy.Int J Clin Oncol2019https://conductscience.org/library/papers/30353257PubMed
27399795Testosterone Level in Testicular Cancer Patients after Chemotherapy.West Indian Med J2015https://conductscience.org/library/papers/27399795PubMed
22528369Oncofertility and the male cancer patient.Curr Treat Options Oncol2012https://conductscience.org/library/papers/22528369PubMed
21403662Complications associated with chemotherapy in testicular cancer management.Nat Rev Urol2011https://conductscience.org/library/papers/21403662PubMed
17848741Long-term complications of platinum-based chemotherapy in testicular cancer survivors.Med Oncol2007https://conductscience.org/library/papers/17848741PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14734005

GET https://conductscience.org/api/papers/v1/14734005/authors